Purchase Order W81K0022P0258
Award Date
10/1/22
Potential Completion Date
9/30/23
Potential Value
$659K
Federal Agency
Medical Command
Awardee
Boston Scientific Corp
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Medical Command awarded a $639,000 firm fixed price purchase order to Boston Scientific Corporation for TheraSphere doses. TheraSphere is an FDA-approved radioactive microsphere therapy used to treat primary liver cancer. The solicitation indicated intent to make a sole source award to Boston Scientific under FAR 13.501(a)(1)(ii) for supplying TheraSphere to treat patients at Regional Health Command Central medical facilities. Interested parties were provided until...
The U.S. Department of the Army Medical Command awarded a sole source Firm-Fixed-Price contract to Boston Scientific Corp., doing business as Boston Scientific, for the procurement of Yttrium 90, a liver cancer therapy, for the Interventional Department of Radiology at Brooke Army Medical Center, Joint Base San Antonio-Fort Sam Houston, TX. The contract is valued at $420,000.00 and has an ultimate completion date of September 30, 2025. This contract was awarded without the use of a set-aside and...
The U.S. Department of Veterans Affairs (VA) has awarded a sole-source, firm-fixed-price contract to Boston Scientific Corp for the supply of Y-90 TheraSphere doses and associated administration materials. The contract, valued at $777,740.00, covers an initial 2-year base period from October 1, 2022, to September 30, 2024, with an option to extend for an additional year through September 30, 2024. This contract is not set-aside. The Y-90 TheraSphere doses are used for the treatment of liver...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Boston Scientific Corp. for the provision of Yttrium-90 TheraSpheres, a radioactive microsphere treatment for primary liver cancer. The contract has a ceiling value of $1,668,770.00 and a period of performance ending on March 31, 2026. The original solicitation was a pre-solicitation notice seeking market research for a potential 5-year blanket purchase agreement (BPA) to supply Yttrium-90...
The Department of Veterans Affairs (VA) Veterans Health Administration has awarded a sole source purchase order contract to Boston Scientific Corp, doing business as Boston Scientific, to provide a 12-month supply of Therasphere Yttrium-90 (Y-90) radiopharmaceutical doses. The $143,960.00 firm fixed price contract will support the Dayton VA Medical Center's Nuclear Medicine Department in treating hepatocellular carcinoma. As the exclusive manufacturer of Therasphere, Boston Scientific was...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Boston Scientific Corp, a for-profit medical device manufacturer, to provide TheraSphere yttrium-90 glass microsphere radiotherapy treatments. The $230,050 contract has a completion date of September 30, 2022. No set-aside designation was used. The TheraSphere treatment involves infusing microscopic radioactive glass microspheres into the arteries feeding liver tumors to deliver high...
The Department of Veterans Affairs (VA) awarded a $121,250 firm fixed price purchase order to Boston Scientific Corp for TheraSphere Y-90 cancer treatment, including the TheraSphere radioactive microspheres, administration kits, and administration sets. This order was placed through the VA's Greater Los Angeles Healthcare System to support radioembolization procedures for non-operable liver cancer patients. The purchase order has a one-year period of performance and does not include a...
The Department of Veterans Affairs awarded a $215,695 purchase order to Boston Scientific Corporation to provide TheraSphere Y-90 radioactive microspheres in unit dose form for treatment of hepatocellular carcinoma at the Phoenix VA Health Care System. This award was made non-competitively under the authority of FAR 6.302-1 as Boston Scientific was determined to be the only responsible source able to meet the agency's requirement for the ready-to-use radiopharmaceutical supplies as specified...
This is a federal contract awarded by the Defense Health Agency to Boston Scientific Corp, doing business as Boston Scientific, for the delivery of Y-90 glass TheraSphere radioactive microspheres to be used at the Tripler Army Medical Center in Hawaii. The contract has a ceiling value of $60,000.00 and a completion date of September 30, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. There is no set-aside designation mentioned for this award. Boston...
Boston Scientific Corporation, doing business as Boston Scientific, was awarded a $313,200 firm fixed price delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 to provide Yttrium-90 TheraSphere radioactive microspheres. This delivery order was issued against the company's existing indefinite delivery contract with the VA worth up to $295 million over five years to supply surgical implants and related services. No set-aside...